KYNB CIK: 921299

Kyntra Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.47
FY22:
0.49
FY23:
0.33
FY24:
0.20
FY25:
0.10
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.30
FY22:
0.12
FY23:
0.09
FY24:
0.02
FY25:
0.02
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.77
FY22:
0.61
FY23:
0.42
FY24:
0.21
FY25:
0.12

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.23
FY22:
0.27
FY23:
0.22
FY24:
0.13
FY25:
0.03
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.32
FY22:
0.34
FY23:
0.37
FY24:
0.26
FY25:
0.09
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.21
FY22:
−0.02
FY23:
−0.20
FY24:
−0.23
FY25:
−0.03

All amounts in billions USD Data source:SEC EDGAR